These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 7814163

  • 1. Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease.
    Bahl VK, Vaswani M, Thatai D, Wasir HS.
    Int J Cardiol; 1994 Sep; 46(2):143-9. PubMed ID: 7814163
    [Abstract] [Full Text] [Related]

  • 2. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R, Vasisht S, Bahl VK, Wasir HS.
    Int J Cardiol; 1996 Dec 13; 57(3):265-70. PubMed ID: 9024915
    [Abstract] [Full Text] [Related]

  • 3. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK, Chang SA, Choi EK, Kim YJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS.
    Int J Cardiol; 2005 Jun 08; 101(3):435-40. PubMed ID: 15907412
    [Abstract] [Full Text] [Related]

  • 4. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease.
    Reinhart RA, Gani K, Arndt MR, Broste SK.
    Arch Intern Med; 1990 Aug 08; 150(8):1629-33. PubMed ID: 2116785
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
    Marcovina S, Zoppo A, Graziani MS, Vassanelli C, Catapano AL.
    Ric Clin Lab; 1988 Aug 08; 18(4):319-28. PubMed ID: 3150125
    [Abstract] [Full Text] [Related]

  • 6. Lipid abnormalities in Greek patients with coronary artery disease.
    Elisaf MS, Siamopoulos KC, Tselegarides TJ, Bairaktari ETh, Goudevenos JA, Tselepis AD, Tsolas OE, Sideris DA.
    Int J Cardiol; 1997 Apr 18; 59(2):177-84. PubMed ID: 9158172
    [Abstract] [Full Text] [Related]

  • 7. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
    Ford ES, Cooper RS, Simmons B, Castaner A.
    J Clin Epidemiol; 1990 Apr 18; 43(5):425-32. PubMed ID: 2109048
    [Abstract] [Full Text] [Related]

  • 8. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R, Kutsumi Y, Hayashi T, Nishio H, Koshino Y, Shimada Y, Nakai T, Miyabo S.
    Am J Cardiol; 1995 Jan 15; 75(2):122-6. PubMed ID: 7810485
    [Abstract] [Full Text] [Related]

  • 9. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW, Demacker PN, Hendriks JC, Brenninkmeijer BJ, Stuyt PM.
    Atherosclerosis; 1989 May 15; 77(1):59-67. PubMed ID: 2719763
    [Abstract] [Full Text] [Related]

  • 10. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
    Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F.
    Atherosclerosis; 2002 Jun 15; 162(2):381-9. PubMed ID: 11996958
    [Abstract] [Full Text] [Related]

  • 11. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM, Weich HF, Weight MJ, Faber M, Kruger M, Lombard CJ, Benadé AJ.
    Coron Artery Dis; 1994 Apr 15; 5(4):331-8. PubMed ID: 8044345
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT, van Lennep JE, van Lennep HW, Liem AH, de Boo JA, van der Schouw YT, Erkelens DW.
    Arterioscler Thromb Vasc Biol; 1998 Jul 15; 18(7):1101-7. PubMed ID: 9672070
    [Abstract] [Full Text] [Related]

  • 13. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A, Marniemi J, Inberg M, Maatela J, Alanen E, Niittymäki K.
    Atherosclerosis; 1986 Feb 15; 59(2):215-21. PubMed ID: 3083832
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B, Bai H, Liu R, Kumagai K, Itabe H, Takano T, Saku K.
    Metabolism; 2004 Apr 15; 53(4):423-9. PubMed ID: 15045686
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
    Kukita H, Hamada M, Hiwada K, Kokubu T.
    Atherosclerosis; 1985 May 15; 55(2):143-9. PubMed ID: 3924067
    [Abstract] [Full Text] [Related]

  • 19. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC, Zago AJ, Campos M, Alves A, Brisolara ML, de Souza J, Candiago RH, Kirschnick L, Ribeiro L, Ordovás K, Leitão C, Cruz R.
    Arq Bras Cardiol; 1999 Jun 15; 72(6):657-68. PubMed ID: 10752172
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.